Language
National
International
Analysis
Opinion
Business
Personal Finance
Sports
Technology
Lifestyle
Entertainment
Language
National
International
Analysis
Opinion
Business
Personal Finance
Sports
Technology
Lifestyle
Entertainment
Authors
{{#static_pages}}
{{ name }}
{{/static_pages}}
You have successfully subscribed the newsletter.
Advertisment
monotherapy
AstraZeneca India receives DCGI's nod to market drug treating breast cancer
Drug firm AstraZeneca India on Friday said it has received an approval from the Drugs Controller General of India to market its drug for the treatment of breast cancer. The Drugs
Subscribe to our Newsletter!
Be the first to get exclusive offers and the latest news
Subscribe Now
Advertisment
Subscribe
Select Language
English
Hindi
Share this article
If you liked this article share it with your friends.
they will thank you later
Facebook
Twitter
Whatsapp
Copied!